Related Experiment Video
Updated: Aug 14, 2025

Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
Olmesartan-induced enteropathy associated with antiphospholipid syndrome
Jorge Collado-Saenz1, Ramón Baeza-Trinidad2, Rafael Daroca-Pérez2
1Medicina Interna , Hospital Universitario San Pedro, España.
None:
Olmesartan-induced enteropathy (OIE) is an emergent enteropathy related to this angiotensin II receptor blocker. Main clinical manifestation is chronic diarrhea and duodenal biopsy is characterized by villous atrophy. Therefore, it is necessary to exclude other causes of enteropathy such as celiac disease, autoimmune enteropathy, intestinal lymphoma, parasitic infections, immunodeficiencies, or Crohn disease. Although it is supposed to be triggered by an immune mechanism, it is not clear its relation to other autoimmune disorders. We report for the first time a case of OIE associated with antiphospholipid syndrome.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Antihypertensive Drugs: Potassium-Sparing Diuretics
Drugs for Treatment of Ulcerative Colitis in IBD
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Nephrotic Syndrome II : Assessment and Medical Management

